Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSNicotinic acid, also known as niacin, is an antagonist of hydroxycarboxylic acid receptor 2 (HCA2), known previously as GPR109A (Ki = 113 nM).1 Nicotinic acid reduces lipolysis in primary human adipocytes (IC50 = 200 nM).2 It reduces the invasion of AH109A-TC cancer cells when used at concentrations of 20 and 40 µM.3 Nicotinic acid increases cutaneous vasodilation in normotensive mice in a dose-dependent manner.4 Formulations containing nicotinic acid have been used in the treatment of hyperlipidemia.
WARNING This product is not for human or veterinary use.
1. PUMA-
2. Phenolic acids suppress adipocyte lipolysis via activation of the nicotinic acid receptor GPR109A (HM74a/PUMA-
3. Anti-
4. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-